Treatment of recurrent gastrointestinal haemorrhage in a patient with von Willebrand's disease with octreotide LAR and propranolol [7]

Gut

Volumn 54, Issue 1, 2005, Pages 171-172

  Krikis, N ^a   Tziomalos, K ^a   Perifanis, V ^a   Vakalopoulou, S ^a   Karagiannis, A ^a   Garipidou, V ^a   Harsoulis, F ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

LONG ACTING DRUG; OCTREOTIDE; PROPRANOLOL; TRANEXAMIC ACID; VON WILLEBRAND FACTOR;

ADULT; BLEEDING DISORDER; CASE REPORT; DRUG EFFICACY; GASTROINTESTINAL HEMORRHAGE; HUMAN; LETTER; MALE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; RECURRENT DISEASE; SUSTAINED RELEASE PREPARATION; VON WILLEBRAND DISEASE;

EID: 10844273248     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2004.049031     Document Type: Letter

References (10)

1. Rizza C. Von Willebrand's disease. In: Rizza C, Lowe G, eds. Haemophilia and other inherited bleeding disorders. London: WB Sounders Company Ltd, 1997:103-9.
2. Mannuci PM. How I treat patients with von Willebrand disease. Blood 2001;97:915-19.
3. Lamberts S, van der Lely AJ, de Herder WW, et al. Octreotide. N Engl J Med 1996;25:246-54.
4. Gillis JC, Noble S, Goa KL. Octreotide long-acting release (LAR). A review of its pharmacological properties and therapeutic use in the management of acromegaly. Drugs 1997;4:681-99.
5. Orsi P, Guatti-Zuliani C, Okolicsanyi L. Long-acting octreotide is effective in controlling rebleeding angiodysplasia of the gastrointestinal tract. Dig Liver Dis 2001;33:330-4.
6. Andersen MR, Aaseby J. Somatostatin in the treatment of gastrointestinal bleeding caused by angiodysplasia. Scand J Gastroenterol 1996;31:1037-9.
7. Rossini FP, Arrigoni A, Pennazio M. Octreotide in the treatment of bleeding due ta angiodysplasia of the small intestine. Am J Gastroenterol 1993;9:1424-7.
8. Nardone G, Rocco A, Balzano T, et al. The efficacy of octreotide therapy in chronic bleeding due to vascular abnormalities of the gastrointestinal tract. Aliment Pharmacol Ther 1999;11:1429-30.
9. Anthony LB. Long-acting formulations somatostatin analogues. Ital J Gastroenterol Hepatol 1999;31:216-18.
10. Bowers M, McNulty O, Mayne E. Octreotide in the treatment of gastrointestinal bleeding caused by angiodysplasia in two patients with von Willebrand's disease. Br J Haematol 2000;108:524-52.